Connect with us

Health & Wellness

Facilitator Model for Public Health Reporting is Launched by NCPDP

Avatar

Published

on

Facilitator Model for Public Health Reporting is Launched by NCPDP

The National Council for Prescription Drug Programs (NCPDP) shall put standards into place that provide access to real-time data to help public health reporting in times of crisis.

Nov 1st, 2022 – The National Council for Prescription Drug Programs (NCPDP), a CMS Designated Standards Maintenance Organization, has declared the beginning of the implementation of its National Facilitator Model, which intends to facilitate public health reporting to boost pandemic and epidemic interventions.

Public health data systems’ poor emergency reaction to COVID-19 (link – https://ehrintelligence.com/features/how-health-information-exchange-can-support-public-health-equity )was caused by interoperability issues and other flaws. Before the pandemic, there were problems with patient data sharing and public health reporting, but when the COVID-19 pandemic casued a significant effect on the healthcare sector, these two health IT problems grew in importance.

The underdeveloped public healthcare system and lack of disaster preparedness highlighted a need for enhanced real-time patient health data interchange and access.

The COVID-19 pandemic and the opioid crisis revealed, among other things, care gaps that were addressed by pharmacists and issues with the existing public health infrastructure, according to Lee Ann Stember, president and CEO of NCPDP.

“And while there has been significant support for updating our public health infrastructure and removing data silos, pharmacists as well as other providers continue to lack access to comprehensive, real-time data from the entire healthcare ecosystem at the point-of-care to support clinical decision-making.”

The NCPDP Real-Time Prescription Benefits data standards and technologies, which have eased access to real-time pharmacy data, will be used with the National Facilitator Model. Under this use case, these industry standards will enable access to real-time data about prescriptions, tests, immunizations, and other pharmacy data by pharmacies, prescribers, and governmental organizations.

“The National Facilitator Model pilot program has my personal and professional support. It has been operational for nine years to assist stem the opioid epidemic and alert prescribers and pharmacists to possible abuse or misuse before an opioid is even administered, according to Stember.

Well beyond the opioid epidemic, all public health concerns have been addressed using the model as a result of the COVID-19 pandemic, according to Stember. “Congressional leaders, business organizations, and others in the healthcare sector have strongly supported the idea. In order for it to be widely adopted and used for epidemic and pandemic responses and public health surveillance, the private sector must advance it and make it operational.

A number of phases will be included in the project to enhance public health infrastructure(link – https://ehrintelligence.com/news/star-hie-program-supports-public-health-agencies-throughout-covid-19 ) between states.

According to NCPDP, pharmacists will access, observe, and report information about the COVID-19 vaccine series in Phase 1 to promote workflow-enabled efficiency, data integration, and real-time data availability.

According to Stember, “The NCPDP National Facilitator Model intends to make that feasible by employing the similar interoperable industry standards that facilitate prescribers’ instant transmission, change, and discontinuation of prescriptions today, as well as prescribers’ quick access to eligibility, pharmacy claim billing, and prior authorization for pharmacists.” “This pilot is essential; we must act now before the next epidemic strikes,”

It took a team effort to make the National Facilitator Model practicable. As the primary researcher and National Facilitator Registry, health IT provider STChealth will take part in the project.

Additionally, the Lee Ann Stember Endowment, Founders Gift Donors FDB (First Databank), GoodRx, and its general fund contributed to the NCPDP Foundation grant.

“FDB is happy to join NCPDP and support the expansion of the National Facilitator Model. “Clinicians and responding agencies must have ready access to and the capacity to share comprehensive, adaptable, and intuitive medication data in order to manage the well-being of individuals and populations pro-actively, particularly during a public health emergency,” said FDB President Bob Katter, who also serves as the patient safety chair for the NCPDP Foundation’s new National Advisory Council.

In addition, patient-specific health as well as medication data “assist identify at-risk individuals and suggest proactive next measures,” Katter continued. “The National Facilitator Model is a natural continuation of our decades-long cooperation with NCPDP through which we supply reliable drug expertise and interoperability capabilities to enable healthcare professionals in executing their crucial workflows,” the company claims.

Jonas Muthoni is an entrepreneur who loves to read books and learn new things. He is the founder of inProfileDaily.com, a website dedicated to bringing the latest news and information about Entertainment and Lifestyle to the public.

Health & Wellness

By Leveraging the Power of Health and Wellness, Michelle Jones has Become a Beacon of Hope for Numerous families in her Local Community

Avatar

Published

on

By Leveraging the Power of Health and Wellness, Michelle Jones has Become a Beacon of Hope for Numerous families in her Local Community

Deborah Jones was always passionate about sports and fitness, but it took years to attain a fitness-training certification. After four long months of traveling to Spanish Town every Saturday morning, Deborah finally earned her certification in Sports Education. She returned to the industry with more confidence than ever before.

It wasn’t long before she started getting requests for help from women who wanted to take their health into their own hands. Deborah’s dedication began to inspire these women, and they saw her as a role model and accountability partner on their path toward reaching their goals. With an increasing clientele, Deborah knew she had to expand with more equipment to offer better services; thus, in December 2022, her dream of creating a successful business became a reality.

At present, Deborah focuses primarily on female clients and generational-health practices. She creates a safe space where everyone is accepted regardless of their background or status quo. For many ladies who come to her gym for support, burdens are lifted without having to share any personal details. In her opinion, in this way, confidence can be gained, insecurities can be worked on, and feelings of overall well-being can be developed.

In addition to providing weight loss programs, strength training classes, endurance training sessions, crossfit courses, functional training regimens, and boot camp services, Deborah also emphasizes teaching people within households how important it is to adopt healthy lifestyles. Research shows that even small increases in cholesterol can greatly increase one’s risk of having a heart attack. Therefore, meal planning and prepping have become a team effort at Deborah’s gym as sisters, mothers, and daughters couples work out together while learning the importance of being physically active. Working out together helps one stay committed and builds balance and accountability among family members while promoting fun activities that bring everyone closer together.

Looking ahead into the future, Deborah seeks satisfaction for women and male clients by incorporating more services, such as physiotherapy for those suffering from physical challenges and pre-and postnatal wellness services for mothers, as well as expanding her merchandise line for those who want something extra special from her brand. Furthermore, she is determined to build a stronger clientele base with a reliable, supportive team behind her. To sum up, Deborah’s main goal is to help people become better versions of themselves physically, mentally, emotionally & spiritually.

Continue Reading

Health & Wellness

Struggling to Shed those Extra Pounds? A Recent Study Reveals that Reducing Caloric Intake may be more Effective as Compared to Intermittent Fasting

Avatar

Published

on

Struggling to Shed those Extra Pounds? A Recent Study Reveals that Reducing Caloric Intake may be more Effective as Compared to Intermittent Fasting

Recent research indicates that some individuals can reach their desired weight without limiting their eating time.

A recent study discovered that those who ate more frequent large or medium meals were substantially prone to putting on extra pounds.

Experts suggest several small meals throughout the day may help individuals dodge unwanted weight gain.

According to experts, eating healthy and getting the right nutrition is important to maintaining a healthy weight. Nutrition includes protein, fiber, healthy fats, vitamins, and minerals, all of which are necessary to maintain good health.

For many people, it can be difficult to get enough nutrition in their diet. As such, registered dietician Stephanie Rapozo advises her clients to eat three times a day. She stresses that it does not have to necessarily be a full meal; snacks can also contribute to daily nutrition needs as long as they are balanced with the right nutrients.

In a recent study at Harvard University, researchers examined the relationship between meal frequency and size and weight change. The study found that there was indeed a link between the two factors; however, this was only an observational study and therefore did not prove direct cause-and-effect relationships. Additionally, participants had to estimate the size of their meals which could be difficult for some, given how subjective it is.

William Dietz Jr., an obesity researcher and professor of global health at George Washington University, noted this difficulty regarding conducting studies on meal timing and size due to individual differences in how people respond to different approaches, such as intermittent fasting or eating within an 11-hour window (which has been associated with weight loss according to two small pilot studies). In contrast, one larger randomized controlled trial found that fasting for 16 hours each day had no more noticeable impact on weight loss than simply eating regularly throughout the day.

Registered dietician Rapozo has seen success with some clients who have adopted shorter eating windows, such as 11-12 hours per day by stopping eating several hours before bedtime; however, she cautions that those who lose weight by doing so often end up consuming fewer calories overall anyway – so it may not necessarily be attributed specifically to the shorter time frame itself.

Ali suggests utilizing portion guides as well – something like a printable plate template – which can help individuals become more mindful about what they’re eating and how much they’re consuming in terms of quantity and calories.

It should be emphasized, though, that when trying to meet health goals, extreme measures should be avoided since they can lead to disordered eating patterns, especially among people who are more at risk due to having certain biological or temperamental factors such as genetics or increased depression or anxiety levels. Nutritionist Allison Chase recommends seeking professional support instead, which takes into account each person’s circumstances, including their physical and mental health state; additionally, engaging in healthy activities like mindfulness or social interaction can help without needing to rely on unhealthy strategies for reaching goals.

Continue Reading

Health & Wellness

J&J’s Hiv Vaccine Program has been Discontinued due to Unsuccessful Results from its Phase 3 Trial

Avatar

Published

on

J&J's Hiv Vaccine Program has been Discontinued due to Unsuccessful Results from its Phase 3 Trial

Pharmaceutical giant Johnson & Johnson has announced that it is ending its phase 3 clinical trial of an HIV vaccine, known as Mosaico after the shot failed to perform better than the placebo. This marks a major setback in the decades-long search for a vaccine that could prevent one of the world’s most devastating diseases.

In a statement released Wednesday, Penny Heaton, Janssen’s global vaccine lead, expressed disappointment at the news but vowed that the company would keep working to find an effective HIV vaccine. She said that the data gathered by Mosaico might help in future efforts.

The trial was launched in 2019 and sought to recruit nearly 4,000 people – primarily gay and bisexual men and transgender individuals – at risk of being infected with HIV. According to Centers for Disease Control (CDC) data from 2016, these populations made up more than half of all cases of HIV infection worldwide and accounted for most new diagnoses. Even more concerningly, research from 2010 showed transgender women were almost 49 times more likely than other adults their age to contract HIV. It is a setback for Janssen and those worldwide who have been fighting to end HIV/AIDS.

Mosaico involved four doses of Johnson & Johnson’s adenovirus vector vaccine over a year and soluble protein injections on visits three and four. The study was conducted through a partnership between Johnson & Johnson, the National Institutes of Health (NIH), and the United States Army Medical Research and Development Command (USAMRDC).

Mosaico’s failure follows another trial known as Imbokodo, which also tested an HIV vaccine developed by J&J but ultimately found it was only 25% effective; even then, results were just outside confidence intervals indicating there may not have been any benefit at all.

The news adds yet another setback in vaccine development for J&J, which recently saw its single-dose COVID-19 vaccine become largely obsolete after two shots administered separately proved much more effective against COVID-19 infection rates than its product. Likewise, Moderna Inc. too has surpassed J&J in the development of an RSV (respiratory syncytial virus) vaccine candidate as part of their collaborative effort with Merck & Co., Inc., having submitted the first applications for regulatory approval last month, whereas J&J trails behind with no timelines given on when their own RSV candidate might be ready for authorization or distribution yet.

Overall this marks another disappointing result in the global fight against HIV/AIDS, which has been ongoing since the 1980s when AIDS first surfaced in America without much knowledge about what caused it or how best to prevent it from spreading further. While we still lack an approved vaccine to protect us against this deadly virus today, researchers remain hopeful that one-day science will provide such protection so that no one will ever have to suffer unnecessarily from AIDS again.

Continue Reading